Recommendations for prevention of hepatitis B with vaccine, Gary B. Calandra and David J. West; plasma-derived hepatitis B vaccine - a breakthrough in preventive medicine, Maurice R. Hilleman; functions of hepatitis B virus proteins and molecular targets for protective immunity, Wolfram H. Gerlich and Volker Bruss; survey of licensed hepatitis B vaccines and their production processes, Robert D. Sitrin et al; quality control of hepatitis B vaccine, Victor P. Grachev and David I. Magrath; serological assays, William J. Miller; epidemiology of hepatitis B virus infection, Stephen C. Hadler and Harold S. Margolis; scope and design of hepatitis B vaccine clinical trials, David J. West; overview of clinical trials in low-endemic areas, Catherine L. Troisi and F. Blaine Hollinger; overview of clinical studies in developing countries, Pierre Coursaget and Mark A. Kane; hepatitis B vaccination - overview of clinical studies in the Far East, E.K. Yeoh and Betty Young; protective efficacy of hepatitis B vaccines in infants, children and adults, Brian J. McMahon and Robert B. Wainwright; prevention of hepatocellular carcinoma, Juei-Low Sung et al; hepatitis B vaccination of children in endemic areas, Alexander Milne and Christopher D. Moyes; prevention of hepatitis B virus infection among health-care workers, Eric E. Mast and Miriam J. Alter; global control of hepatitis B through universal infant immunization, Mark A. Kane; needs unfulfilled by current hepatitis B vaccines, Patricia L. Hibberd et al; variant hepatitis B and D viruses, Tim J. Harrison and Arie J. Zuckerman; application of synthetic peptide technology to experimental hepatitis B vaccine design, David R. Milich; potential future recombinant vaccines, Tineke Rutgers et al.